Literature DB >> 21909813

Epigallocatechin gallate inhibits sphere formation of neuroblastoma BE(2)-C cells.

Noriyuki Nishimura1, Tri Budi Hartomo, Thi Van Huyen Pham, Myeong Jin Lee, Tomoto Yamamoto, Satoru Morikawa, Daiichiro Hasegawa, Hiroki Takeda, Keiichiro Kawasaki, Yoshiyuki Kosaka, Nobuyuki Yamamoto, Ikuko Kubokawa, Takeshi Mori, Tomoko Yanai, Akira Hayakawa, Yasuhiro Takeshima, Kazumoto Iijima, Masafumi Matsuo, Hisahide Nishio.   

Abstract

OBJECTIVES: A growing number of epidemiological studies have demonstrated that the consumption of green tea inhibits the growth of a variety of cancers. Epigallocatechin gallate (EGCG), the most abundant catechin in green tea, has been shown to have an anti-cancer effect against many cancers. Most cancers are believed to be initiated from and maintained by a small population of tumor-initiating cells (TICs) that are responsible for chemotherapeutic resistance and tumor relapse. In neuroblastoma, an aggressive pediatric tumor that often relapses and has a poor prognosis, TICs were recently identified as spheres grown in a serum-free non-adherent culture used for neural crest stem cell growth. Although EGCG has been reported to induce growth arrest and apoptosis in neuroblastoma cells, its effect on neuroblastoma TICs remains to be defined.
METHODS: Gene expression was analyzed by real-time reverse transcription polymerase chain reaction (RT-PCR). The effects of EGCG on cell proliferation, apoptosis, and sphere formation were determined by cell counting, propidium iodide staining, and sphere (>100 μm in diameter) counting, respectively.
RESULTS: Neuroblastoma BE(2)-C cells showed increased expression of stem cell markers (nanog homeobox [NANOG] and octamer-binding transcription factor 4 [OCT4]), as well as decreased expression of neuronal differentiation markers (Cu(2+)-transporting ATPase alpha polypeptide [ATP7A] and dickkopf homolog 2 [DKK2]) in spheres grown in serum-free non-adherent culture, compared to parental cells grown in conventional culture. Although EGCG induced growth arrest and apoptosis in the parental cells in a dose-dependent manner, it was not effective against spheres. However, EGCG potently inhibited sphere formation in the BE(2)-C cells.
CONCLUSIONS: The present results suggest that EGCG may inhibit the development of TICs in BE(2)-C cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21909813      PMCID: PMC3348241          DOI: 10.1007/s12199-011-0239-5

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  30 in total

1.  Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state.

Authors:  Christine L Chaffer; Ines Brueckmann; Christina Scheel; Alicia J Kaestli; Paul A Wiggins; Leonardo O Rodrigues; Mary Brooks; Ferenc Reinhardt; Ying Su; Kornelia Polyak; Lisa M Arendt; Charlotte Kuperwasser; Brian Bierie; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-15       Impact factor: 11.205

2.  Rab15 expression correlates with retinoic acid-induced differentiation of neuroblastoma cells.

Authors:  Noriyuki Nishimura; Thi Van Huyen Pham; Tri Budi Hartomo; Myeong Jin Lee; Daiichiro Hasegawa; Hiroki Takeda; Keiichiro Kawasaki; Yoshiyuki Kosaka; Tomoto Yamamoto; Satoru Morikawa; Nobuyuki Yamamoto; Ikuko Kubokawa; Takeshi Mori; Tomoko Yanai; Akira Hayakawa; Yasuhiro Takeshima; Hisahide Nishio; Masafumi Matsuo
Journal:  Oncol Rep       Date:  2011-04-12       Impact factor: 3.906

3.  A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

Authors:  Alexander Roesch; Mizuho Fukunaga-Kalabis; Elizabeth C Schmidt; Susan E Zabierowski; Patricia A Brafford; Adina Vultur; Devraj Basu; Phyllis Gimotty; Thomas Vogt; Meenhard Herlyn
Journal:  Cell       Date:  2010-05-14       Impact factor: 41.582

4.  Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion.

Authors:  Dimitrios Iliopoulos; Heather A Hirsch; Guannan Wang; Kevin Struhl
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

Review 5.  Stem cells in cancer: instigators and propagators?

Authors:  Malcolm R Alison; Shahriar Islam; Nicholas A Wright
Journal:  J Cell Sci       Date:  2010-07-15       Impact factor: 5.285

6.  Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.

Authors:  Yanyan Li; Tao Zhang; Hasan Korkaya; Suling Liu; Hsiu-Fang Lee; Bryan Newman; Yanke Yu; Shawn G Clouthier; Steven J Schwartz; Max S Wicha; Duxin Sun
Journal:  Clin Cancer Res       Date:  2010-04-13       Impact factor: 12.531

Review 7.  Neuroblastoma: biological insights into a clinical enigma.

Authors:  Garrett M Brodeur
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

8.  Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells.

Authors:  Claudia Kürbitz; Daniel Heise; Torben Redmer; Freya Goumas; Alexander Arlt; Johannes Lemke; Gerald Rimbach; Holger Kalthoff; Anna Trauzold
Journal:  Cancer Sci       Date:  2011-02-24       Impact factor: 6.716

9.  Genes involved in regulation of stem cell properties: studies on their expression in a small cohort of neuroblastoma patients.

Authors:  Mariarosa A B Melone; Maria Giuliano; Tiziana Squillaro; Nicola Alessio; Fiorina Casale; Eliseo Mattioli; Marilena Cipollaro; Antonio Giordano; Umberto Galderisi
Journal:  Cancer Biol Ther       Date:  2009-07       Impact factor: 4.742

10.  Targeting breast stem cells with the cancer preventive compounds curcumin and piperine.

Authors:  Madhuri Kakarala; Dean E Brenner; Hasan Korkaya; Connie Cheng; Karim Tazi; Christophe Ginestier; Suling Liu; Gabriela Dontu; Max S Wicha
Journal:  Breast Cancer Res Treat       Date:  2009-11-07       Impact factor: 4.872

View more
  9 in total

Review 1.  Natural compounds for pediatric cancer treatment.

Authors:  Veronica Ferrucci; Iolanda Boffa; Gina De Masi; Massimo Zollo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-09       Impact factor: 3.000

2.  (-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation.

Authors:  Ya-Jun Li; Shun-Long Wu; Song-Mei Lu; Fang Chen; Ying Guo; Sheng-Min Gan; Yan-Long Shi; Shuang Liu; Shao-Lin Li
Journal:  Tumour Biol       Date:  2014-12-07

Review 3.  Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate.

Authors:  Hirota Fujiki; Eisaburo Sueoka; Anchalee Rawangkan; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-23       Impact factor: 4.553

4.  A new promising way of maintenance therapy in advanced ovarian cancer: a comparative clinical study.

Authors:  Vsevolod I Kiselev; Levon A Ashrafyan; Ekaterina L Muyzhnek; Evgeniya V Gerfanova; Irina B Antonova; Olga I Aleshikova; Fazlul H Sarkar
Journal:  BMC Cancer       Date:  2018-09-20       Impact factor: 4.430

5.  Epigallocatechin-3-gallate and 6-OH-11-O-Hydroxyphenanthrene Limit BE(2)-C Neuroblastoma Cell Growth and Neurosphere Formation In Vitro.

Authors:  Fulvia Farabegoli; Marzia Govoni; Enzo Spisni; Alessio Papi
Journal:  Nutrients       Date:  2018-08-22       Impact factor: 5.717

Review 6.  Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier.

Authors:  Hisham F Bahmad; Farah Chamaa; Sahar Assi; Reda M Chalhoub; Tamara Abou-Antoun; Wassim Abou-Kheir
Journal:  Front Mol Neurosci       Date:  2019-05-27       Impact factor: 5.639

Review 7.  Inhibitory Effects of (-)-Epigallocatechin-3-gallate on Esophageal Cancer.

Authors:  Liu-Xiang Wang; Yun-Long Shi; Long-Jie Zhang; Kai-Rong Wang; Li-Ping Xiang; Zhuo-Yu Cai; Jian-Liang Lu; Jian-Hui Ye; Yue-Rong Liang; Xin-Qiang Zheng
Journal:  Molecules       Date:  2019-03-08       Impact factor: 4.411

8.  Modelling human CNS injury with human neural stem cells in 2- and 3-Dimensional cultures.

Authors:  Barbora Vagaska; Olivia Gillham; Patrizia Ferretti
Journal:  Sci Rep       Date:  2020-04-22       Impact factor: 4.379

9.  Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations.

Authors:  Marion M Chan; Rensa Chen; Dunne Fong
Journal:  Cancer Lett       Date:  2018-06-28       Impact factor: 8.679

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.